Last update:

Weight management news

Obesity drugs show early promise against the hormonal disorder PMOS, giving a suffering family hope

Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted facial hair—the same puzzling symptoms that plagued her mom for decades and that no doctor could piece ...

Britain's quarter century: Experts in sex, mental health, nutrition and addiction assess nation's changing well-being

A good way to follow the health of a nation is to glance at what is known as period life expectancy. This calculates how long a person born today would live if the current death rates remained exactly the same for the rest ...

Unexpected brain mechanism challenges assumptions about GLP-1s

For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10% to 15% or more. Despite their success, ...

Recommendations developed for faltering weight in children

In a clinical practice guideline issued by the American Academy of Pediatrics, in partnership with the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, recommendations are presented for the ...

Concerning rise in US teen obesity over a decade

Nearly 1 in 5 teens in the United States is obese, putting their long-term health at serious risk. Obesity in adolescence leads to many deleterious medical conditions including diabetes, high blood pressure, sleep apnea, ...

Experts propose a tobacco playbook for food policy

Diet‑related diseases such as type 2 diabetes, obesity and hypertension, particularly those affecting children, remain stubbornly high. Can public policies like those that have been successful with tobacco control help shape ...

GLP-1 medication changes may support long-term weight management

Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didn't switch, according to a new study by UT Southwestern ...